Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
0.6857
-0.0053 (-0.77%)
At close: Jul 14, 2025, 4:00 PM
0.6787
-0.0070 (-1.02%)
After-hours: Jul 14, 2025, 4:04 PM EDT
Assertio Holdings Market Cap
Assertio Holdings has a market cap or net worth of $65.42 million as of July 14, 2025. Its market cap has decreased by -42.67% in one year.
Market Cap
65.42M
Enterprise Value
19.05M
1-Year Change
-42.67%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since December 1, 1998, Assertio Holdings's market cap has increased from $47.70M to $65.42M, an increase of 37.15%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 66.20M | -20.43% |
| Dec 31, 2024 | 83.20M | -17.87% |
| Dec 29, 2023 | 101.30M | -51.23% |
| Dec 30, 2022 | 207.70M | 113.46% |
| Dec 31, 2021 | 97.30M | 154.05% |
| Dec 31, 2020 | 38.30M | -62.04% |
| Dec 31, 2019 | 100.90M | -56.28% |
| Dec 31, 2018 | 230.80M | -54.50% |
| Dec 29, 2017 | 507.30M | -54.28% |
| Dec 30, 2016 | 1.11B | 1.20% |
| Dec 31, 2015 | 1.10B | 15.87% |
| Dec 31, 2014 | 946.30M | 56.96% |
| Dec 31, 2013 | 602.90M | 73.60% |
| Dec 31, 2012 | 347.30M | 21.01% |
| Dec 30, 2011 | 287.00M | -14.46% |
| Dec 31, 2010 | 335.50M | 92.59% |
| Dec 31, 2009 | 174.20M | 106.89% |
| Dec 31, 2008 | 84.20M | -45.92% |
| Dec 31, 2007 | 155.70M | 7.75% |
| Dec 29, 2006 | 144.50M | -40.61% |
| Dec 30, 2005 | 243.30M | 30.04% |
| Dec 31, 2004 | 187.10M | -21.88% |
| Dec 31, 2003 | 239.50M | 627.96% |
| Dec 31, 2002 | 32.90M | -58.62% |
| Dec 31, 2001 | 79.50M | 152.38% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |